Visura Announces Closing of Series B Financing
Summary
"These significant investments underscore the tremendous confidence in our state-of-the-art solution, experienced team, and the growth trajectory we are on to fully commercialize our TEECAD System," says Christine Horton, president and CEO of Visura. "Visuras TEECAD System is the worlds first FDA-cleared disposable camera that seamlessly connects to TEE probes. TEECAD provides physicians with real-time visualization during esophageal intubation for more efficient and effective probe placement. Use of the TEECAD System for efficient and accurate probe placement with fewer complications supports the healthcare systems goal of zero hospital-acquired complications.In addition to securing Series B funding, Visura recently received a Launch Minnesota Innovation Grant issued by the Minnesota Department of Employment and Economic Development. To bring the technology to heart centers across the U.S., Visura also launched a new product update in 2022, expanding the usage of the TEECAD System to include the Philips X8-2t Transducer.